Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.
Psychiatry May 21st 2024
MDLinx
Recent studies highlight that while meditation is beneficial for many, it can also lead to significant mental health challenges, including anxiety, psychosis, and depersonalization, particularly in intense meditative practices.
Psychiatry May 14th 2024
Healthgrades for Professionals
Vicks VapoRub, a staple in cold treatment, also shows promise in dermatological and pain relief applications. Its efficacy in treating toenail fungus and potential in softening skin highlights its versatility in patient care.
All Specialties March 13th 2024
Neurology Advisor
Explore the potential of tDCS as a non-pharmacological intervention for Alzheimer’s disease, demonstrating significant cognitive improvements linked to enhanced cortical plasticity, without serious adverse effects.
Neurology March 5th 2024
Consultant360
In this video, Dr. Charles Raison reveals how hyperthermia may harness the body’s immune response to combat major depressive disorder, suggesting a potential shift in non-pharmacological treatment strategies.
Psychiatry February 13th 2024
Psychiatrist.com
Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.